SANUWAVE Health to Participate in 37th Annual Roth Conference
SANUWAVE Health (OTCQB: SNWV) announced its participation in the 37th Annual Roth Conference, scheduled for March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California. CEO Morgan Frank will be available for one-on-one meetings with investors throughout the conference.
The Annual Roth Conference is one of the nation's largest small-cap company events, featuring approximately 500 private and public companies from various growth sectors. The conference format includes company presentations, Q&A sessions, and management meetings, covering sectors such as consumer, healthcare, industrial growth, sustainability, and technology.
SANUWAVE Health specializes in non-invasive medical systems for skin, musculoskeletal tissue, and vascular structure regeneration. The company's wound care portfolio utilizes patented energy transfer technologies to support natural healing processes across wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular applications.
SANUWAVE Health (OTCQB: SNWV) ha annunciato la sua partecipazione alla 37ª Conferenza Annuale Roth, prevista per il 16-18 marzo 2025, presso il Laguna Cliffs Marriott Resort & Spa a Dana Point, California. Il CEO Morgan Frank sarà disponibile per incontri individuali con gli investitori durante tutta la conferenza.
La Conferenza Annuale Roth è uno dei più grandi eventi per aziende a bassa capitalizzazione del paese, con circa 500 aziende private e pubbliche provenienti da vari settori in crescita. Il formato della conferenza include presentazioni aziendali, sessioni di domande e risposte e incontri con la direzione, coprendo settori come consumatori, sanità, crescita industriale, sostenibilità e tecnologia.
SANUWAVE Health è specializzata in sistemi medici non invasivi per la rigenerazione della pelle, dei tessuti muscoloscheletrici e delle strutture vascolari. Il portafoglio di prodotti per la cura delle ferite dell'azienda utilizza tecnologie di trasferimento energetico brevettate per supportare i processi di guarigione naturali in applicazioni di guarigione delle ferite, ortopediche/spine, estetiche/cosmetiche e cardiache/endovascolari.
SANUWAVE Health (OTCQB: SNWV) anunció su participación en la 37ª Conferencia Anual Roth, programada del 16 al 18 de marzo de 2025, en el Laguna Cliffs Marriott Resort & Spa en Dana Point, California. El CEO Morgan Frank estará disponible para reuniones uno a uno con inversores durante toda la conferencia.
La Conferencia Anual Roth es uno de los eventos más grandes del país para empresas de pequeña capitalización, con aproximadamente 500 empresas privadas y públicas de varios sectores de crecimiento. El formato de la conferencia incluye presentaciones de empresas, sesiones de preguntas y respuestas y reuniones de gestión, abarcando sectores como el consumidor, la salud, el crecimiento industrial, la sostenibilidad y la tecnología.
SANUWAVE Health se especializa en sistemas médicos no invasivos para la regeneración de la piel, los tejidos musculoesqueléticos y las estructuras vasculares. El portafolio de cuidados de heridas de la empresa utiliza tecnologías de transferencia de energía patentadas para apoyar los procesos de curación natural en aplicaciones de curación de heridas, ortopédicas/columna, estéticas/cosméticas y cardíacas/endovasculares.
SANUWAVE Health (OTCQB: SNWV)는 2025년 3월 16일부터 18일까지 캘리포니아 다나 포인트에 위치한 라구나 클리프 메리어트 리조트 & 스파에서 열리는 제37회 연례 로스 컨퍼런스에 참여한다고 발표했습니다. CEO 모건 프랭크는 컨퍼런스 기간 동안 투자자와의 일대일 미팅을 위해 대기합니다.
연례 로스 컨퍼런스는 약 500개의 민간 및 상장 기업이 다양한 성장 부문에서 참여하는 미국 최대의 소형 기업 이벤트 중 하나입니다. 컨퍼런스 형식은 기업 발표, 질의응답 세션 및 경영진 회의를 포함하며 소비자, 의료, 산업 성장, 지속 가능성 및 기술과 같은 부문을 다룹니다.
SANUWAVE Health는 피부, 근골격 조직 및 혈관 구조 재생을 위한 비침습적 의료 시스템을 전문으로 합니다. 이 회사의 상처 치료 포트폴리오는 상처 치유, 정형외과/척추, 미용/화장품 및 심장/혈관 응용 분야에서 자연 치유 과정을 지원하기 위해 특허받은 에너지 전송 기술을 사용합니다.
SANUWAVE Health (OTCQB: SNWV) a annoncé sa participation à la 37e Conférence Annuelle Roth, prévue du 16 au 18 mars 2025, au Laguna Cliffs Marriott Resort & Spa à Dana Point, Californie. Le PDG Morgan Frank sera disponible pour des réunions individuelles avec les investisseurs tout au long de la conférence.
La Conférence Annuelle Roth est l'un des plus grands événements pour les entreprises à petite capitalisation du pays, réunissant environ 500 entreprises privées et publiques de divers secteurs en croissance. Le format de la conférence comprend des présentations d'entreprises, des sessions de questions-réponses et des réunions de direction, couvrant des secteurs tels que la consommation, la santé, la croissance industrielle, la durabilité et la technologie.
SANUWAVE Health se spécialise dans les systèmes médicaux non invasifs pour la régénération de la peau, des tissus musculo-squelettiques et des structures vasculaires. Le portefeuille de soins des plaies de l'entreprise utilise des technologies de transfert d'énergie brevetées pour soutenir les processus de guérison naturels dans les domaines de la guérison des plaies, de l'orthopédie/de la colonne vertébrale, de l'esthétique/cosmétique et des applications cardiaques/endovasculaires.
SANUWAVE Health (OTCQB: SNWV) gab seine Teilnahme an der 37. jährlichen Roth-Konferenz bekannt, die vom 16. bis 18. März 2025 im Laguna Cliffs Marriott Resort & Spa in Dana Point, Kalifornien, stattfinden wird. CEO Morgan Frank wird während der gesamten Konferenz für persönliche Gespräche mit Investoren zur Verfügung stehen.
Die jährliche Roth-Konferenz ist eines der größten Veranstaltungen für Unternehmen mit kleiner Marktkapitalisierung im Land und umfasst etwa 500 private und öffentliche Unternehmen aus verschiedenen Wachstumssektoren. Das Format der Konferenz umfasst Unternehmenspräsentationen, Frage-und-Antwort-Sitzungen und Managementbesprechungen und deckt Sektoren wie Konsumgüter, Gesundheitswesen, industrielles Wachstum, Nachhaltigkeit und Technologie ab.
SANUWAVE Health spezialisiert sich auf nicht-invasive Medizinsysteme zur Regeneration von Haut, muskuloskelettalen Gewebe und vaskulären Strukturen. Das Wundversorgungsportfolio des Unternehmens nutzt patentierte Energietransfertechnologien, um natürliche Heilungsprozesse in den Bereichen Wundheilung, Orthopädie/Wirbelsäule, ästhetische/kosmetische sowie kardiologische/endovaskuläre Anwendungen zu unterstützen.
- None.
- None.
EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank, Chief Executive Officer, will participate in the 37th Annual Roth Conference to be held on March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California.
Management will be available for one-on-one meetings throughout the conference. Interested investors should contact their Roth representative or email snwv@fnkir.com to schedule a meeting.
About the Roth Conference
The Annual ROTH Conference is one of the largest in the nation for small-cap companies, combining company presentations, Q&A sessions and management 1-on-1 meetings. The format provides investors the opportunity to hear from and meet with executive management from approximately 500 private and public companies in a variety of growth sectors. Roth’s award-winning Research Team identifies distinguished presenting companies across broad sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology and more.
About SANUWAVE
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Contact: investors@sanuwave.com
FAQ
When and where is SANUWAVE Health (SNWV) presenting at the 2025 Roth Conference?
How can investors schedule meetings with SANUWAVE Health (SNWV) at the 2025 Roth Conference?
What are SANUWAVE Health's (SNWV) main product areas and technologies?
What is the scope of the 2025 Roth Conference where SNWV is participating?
